Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 149
Filter
2.
Int. j. cardiovasc. sci. (Impr.) ; 35(2): 161-171, Mar.-Apr. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1364975

ABSTRACT

Abstract Background: There are divergences in the literature regarding the experimental model (Wistar-WIS or Wistar Kyoto-WKY) to be used as a Spontaneously Hypertensive Rat (SHR) control. The characterization of these models in terms of cardiovascular parameters provides researchers with important tools at the time of selection and application in scientific research. Objective: The aim of this study was to evaluate the use of WIS and WKY as a Spontaneously Hypertensive Rat (SHR) control by assessing the long-term behavior of blood pressure and cardiac structure and function in these strains. Methods: To this end, WIS, WKY, and SHR underwent longitudinal experiments. Blood pressure and body mass were measured every two weeks from the 8th to the 72nd. Echocardiographic analysis was performed in all groups with 16, 48, and 72 weeks of life. After having applied the normality test, the Two-Way ANOVA of repeated measures followed by the Tukey post hoc test was used. A significance level of 5% was established. Results: The WIS group showed higher body mass (p<0.05), while the WKY and SHR presented higher body mass variation over time (p<0.05). SHR exhibited increased values of systolic, diastolic, and mean blood pressure when compared to WKY and WIS, whereas the WKY generally showed higher values than WIS (p<0.05). Regarding the cardiac function, SHR showed reduced values, while the WKY presented an early decrease when compared to WIS with aging (p<0.05). Conclusion: WIS is a more suitable normotensive control for SHR than WKY in experiments to test blood pressure and cardiac structure and function.


Subject(s)
Animals , Male , Rats , Hypertension/genetics , Hypertension, Renovascular , Rats, Inbred SHR , Rats, Inbred WKY , Rats, Wistar , Epigenesis, Genetic , Arterial Pressure , Heart Function Tests
3.
Article in Chinese | WPRIM | ID: wpr-878904

ABSTRACT

Hypertension is a clinical syndrome characterized by elevated systemic arterial blood pressure, which may be accompanied by functional or organic damage of heart, brain, kidney and other organs. The pathogenesis and development of hypertension are affected by genetic, environmental, epigenetic, intestinal microbiota and other factors. They are the result of multiple factors that promote the change of blood pressure level and vascular resistance. G protein coupled receptors(GPCRs) are the largest and most diverse superfamily of transmembrane receptors that transmit signals across cell membranes and mediate a large number of cellular responses required by human physiology. A variety of GPCRs are involved in the control of blood pressure and the maintenance of normal function of cardiovascular system. Hypertension contributes to the damages of heart, brain, kidney, intestine and other organs. Many GPCRs are expressed in various organs to regulate blood pressure. Although many GPCRs have been used as therapeutic targets for hypertension, their efficacy has not been fully studied. The purpose of this paper is to elucidate the role of GPCRs in blood pressure regulation and its distribution in target organs. The relationship between GPCRs related to intestinal microorganisms and blood pressure is emphasized. It is proposed that traditional Chinese medicine may be a new way to treat hypertension by regulating the related GPCRs via intestinal microbial metabolites.


Subject(s)
Blood Pressure , GTP-Binding Proteins , Gastrointestinal Microbiome , Humans , Hypertension/genetics , Receptors, G-Protein-Coupled/metabolism
4.
Arq. bras. cardiol ; 115(1): 52-58, jul. 2020. tab, graf
Article in Portuguese | SES-SP, LILACS, SES-SP | ID: biblio-1131252

ABSTRACT

Resumo Fundamento A história familiar de hipertensão (HFH) é um fator de risco consistente para diversas doenças crônicas que são acompanhadas por hipertensão. Além disso, a variabilidade da frequência cardíaca (VFC) e a vasodilatação mediada pelo fluxo (VMF), ambas relacionadas ao consumo máximo de oxigênio (VO2max), são geralmente prejudicadas durante a hipertensão. Objetivo Comparar a modulação autonômica, a função endotelial (FE) e o consumo máximo de oxigênio (VO2max) de jovens atletas, separados de acordo com a história de pressão arterial (PA) dos seus pais, a fim de investigar a influência da ascendência genética nesses parâmetros. Métodos Quarenta e seis jovens jogadores de futebol do sexo masculino (18±2 anos) foram divididos em quatro grupos: 1- pai e mãe normotensos (FM-N); 2- apenas pai hipertenso (F-H); 3- apenas mãe hipertensa (M-H); 4- pai e mãe hipertensos (FM-H). Foram realizadas medições da PA, VMF, VFC e do VO2max. Na análise estatística, foi adotado o nível de significância de 5%. Resultados O desvio padrão dos intervalos RR normais (SDNN; FM-N=314±185; FM-H=182,4± 57,8), a raiz quadrada das médias quadráticas das diferenças dos intervalos R-R sucessivos (RMSSD; FM-N=248±134; FM-H=87±51), o número de diferenças entre intervalos NN sucessivos maiores que 50 ms (NN50; FM-N=367±83,4; FM-H=229±55), a proporção de NN50 dividida pelo número total de NNs (pNN50; FM-N=32,4±6,2; FM-H=21,1±5,3) e os componentes de alta (HF; FM-N=49±8,9; FM-H=35,3±12) e baixa frequência (LF; FM-N=50,9±8,9; FM-H=64,6±12), em unidades normalizadas (%), foram significativamente mais baixos no grupo FM-H do que no grupo FM-N (p<0,05). Por outro lado, a relação LF/HF (ms2) foi significativamente maior (p<0,05). Não foram encontradas diferenças significativas no VO2max e na VMF entre os grupos (p<0,05). Conclusão Em jovens jogadores de futebol do sexo masculino, a HFH desempenha um papel potencialmente importante no comprometimento do balanço autonômico, principalmente quando ambos os pais são hipertensos, mas não apresentam alterações no VO2max e na VMF. Nesse caso, há uma diminuição no controle simpatovagal, que parece preceder o dano endotelial. (Arq Bras Cardiol. 2020; 115(1):52-58)


Abstract Background The family history of hypertension (FHH) imposes consistent risk for diverse chronic diseases that are accompanied by hypertension. Furthermore, the heart rate variability (HRV) and flow-mediated dilation (FMD) are both related to maximal oxygen uptake (VO2max), and are usually impaired during hypertension Objective To compare the autonomic modulation, the endothelial function (EF) and maximum oxygen uptake (VO2max) of young athletes, separated according to their parents' blood pressure (BP) history, in order to study the influence of their genetic background on those parameters. Methods A total of 46 young male soccer players (18±2 years of age) were divided into four groups: 1-normotensive father and mother (FM-N); 2-only father was hypertensive (F-H); 3-only mother was hypertensive (M-H); 4-father and mother were hypertensive (FM-H). Measurements of BP, FMD, HRV and VO2maxwere performed. The significance level adopted in the statistical analysis was 5%. Results The standard deviation of normal RR intervals (SDNN; FM-N=314±185; FM-H=182.4± 57.8), the square root of the mean squared differences in successive RR intervals (RMSSD; FM-N=248±134; FM-H=87±51), the number of interval differences of successive NN intervals greater than 50ms (NN50; FM-N=367±83.4; FM-H=229±55), the ratio derived by dividing NN50 by the total number of NN intervals (pNN50; FM-N=32.4±6.2; FM-H=21.1±5.3) and the high (HF; FM-N=49±8.9; FM-H=35.3±12) and low-frequency (LF; FM-N=50.9±8.9; FM-H=64.6±12) components, in normalized units (%), were significantly lower in the FM-H group than in the FM-N group (p<0.05). On the other hand, the LF/HF ratio (ms2) was significantly higher (p<0.05). We found no significant difference between the groups in VO2maxand FMD (p<0.05). Conclusions In young male soccer players, the FHH plays a potentially role in autonomic balance impairment, especially when both parents are hypertensive, but present no changes in VO2maxand FMD. In this case, there is a decrease in the sympathetic-vagal control, which seems to precede the endothelial damage (Arq Bras Cardiol. 2020; 115(1):52-58)


Subject(s)
Humans , Male , Adolescent , Adult , Young Adult , Soccer , Endothelium/physiopathology , Hypertension/genetics , Oxygen , Oxygen Consumption , Autonomic Nervous System/parasitology , Heart Rate
5.
Article in Chinese | WPRIM | ID: wpr-878774

ABSTRACT

This study aimed to explore the optimal indications and mechanism of Uncariae Ramulus cum Uncis(UR)-Eucommiae Cortex(EC) in lowering blood pressure based on network pharmacology and molecular docking. Chemical constituents were collected and screened by TCMSP database. Swiss Target Prediction platform was used to predict the related targets of the drug. OMIM, TCMIP and GeneCards databases were used to collect hypertension-related genes, and the intersections were taken to obtain potential targets for anti-hypertensive treatment of UR-EC. FunRich software was used to enrich the clinical phenotype and expression site of potential target of lowering blood pressure to analyze and predict the optimal indications of UR-EC. STRING database was used for KEGG pathway enrichment analysis, and Cytoscape 3.7.2 was used to construct the network of "composition-target-pathway". The key targets and their corresponding components in the network were analyzed and obtained, and then molecular docking was applied for preliminary verification. Twenty potential active components of UR and 24 potential active components of EC were respectively collected, and 92 anti-hypertensive potential targets of UR-EC were obtained. According to FunRich enrichment results, the optimal indication of UR-EC was pregnancy hypertension, which involved calcium signaling pathway, HIF-1 signaling pathway, neuroactive ligand receptor interaction, renin vascular tightening, VEGF signaling pathway, etc. In addition, AKT1, NOS2, ADRB2, F2, NOS3, SCN5 A, HTR2 A and JAK2 were considered as the key targets in the network. The molecular docking results showed that the screened potential active components had high binding activity with the key targets. This study preliminarily revealed that UR-EC may have therapeutic effects on pregnancy hypertension in terms of sedation, anti-hypertension, anti-inflammatory, anti-oxidation, improvement of vascular endothelial function and so on.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Humans , Hypertension/genetics , Medicine, Chinese Traditional , Molecular Docking Simulation , Pregnancy
6.
Rev. méd. Chile ; 147(12): 1527-1534, dic. 2019. tab
Article in Spanish | LILACS | ID: biblio-1094186

ABSTRACT

Background Losartan is widely used in many clinicals settings. Its dosage is related to the genetic characteristics of CYP2C9 enzymatic activity, which metabolizes losartan to its active form E-3174, responsible for the antihypertensive effect. Aims To identify the frequency of allelic variants CYP2C9*2 and CYP2C9*3 in hypertensive patients and to compare genotypes with a healthy Chilean population. To relate polymorphisms with the losartan dosing to obtain an optimal blood pressure. Material and Methods We studied 30 patients with controlled essential hypertension using losartan with normal liver function, and 202 healthy people. Peripheral blood DNA genotyping was performed by polymerase chain reaction to identify the polymorphisms. Allelic and genotypic frequencies were compared. Results In hypertensive patients, allelic frequencies were 0.85 (CYP2C9*1), 0.05 (CYP2C9*2) and 0.1 (CYP2C9*3). Genotypic frequencies were 73.3% (CYP2C9*1/*1), 6.7% (CYP2C9*1/*2), 16.7% (CYP2C9*1/*3) and 3.3% (CYP2C9*2/3); observing a significantly higher frequency of the allele CYP2C9*3 (p=0.041) and CYP2C9*1/*3 genotype (p=0.04). A non-significant tendency to need a larger dose of losartan was observed with the CYP2C9 * 3 allele, with an odds ratio (OR) of 1.46 (95% confidence intervals (CI) 0.01-18.64). The same tendency was observed with the need to use losartan twice a day, obtaining an OR of 5.88 (CI 0.54 -62.14). Conclusions There could be a relationship between the presence of CYP2C9 polymorphisms and the pathogenesis of hypertension. The presence of CYP2C9*3 is associated with the need for higher doses of losartan, possibly due to a decrease in the conversion of losartan to E-3174.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Polymorphism, Genetic , Losartan/administration & dosage , Cytochrome P-450 CYP2C9/genetics , Hypertension/genetics , Hypertension/drug therapy , Antihypertensive Agents/administration & dosage , Gene Frequency , Genotype
7.
Arq. bras. cardiol ; 110(2): 166-174, Feb. 2018. tab, graf
Article in English | LILACS | ID: biblio-888024

ABSTRACT

Abstract Background: Individuals with a family history of systemic arterial hypertension (FHSAH) and / or prehypertension have a higher risk of developing this pathology. Objective: To evaluate the autonomic and vascular functions of prehypertensive patients with FHSAH. Methods: Twenty-five young volunteers with FHSAH, 14 normotensive and 11 prehypertensive subjects were submitted to vascular function evaluation by forearm vascular conductance(VC) during resting and reactive hyperemia (Hokanson®) and cardiac and peripheral autonomic modulation, quantified, respectively, by spectral analysis of heart rate (ECG) and systolic blood pressure (SBP) (FinometerPRO®). The transfer function analysis was used to measure the gain and response time of baroreflex. The statistical significance adopted was p ≤ 0.05. Results: Pre-hypertensive individuals, in relation to normotensive individuals, have higher VC both at rest (3.48 ± 1.26 vs. 2.67 ± 0.72 units, p = 0.05) and peak reactive hyperemia (25, 02 ± 8.18 vs. 18.66 ± 6.07 units, p = 0.04). The indices of cardiac autonomic modulation were similar between the groups. However, in the peripheral autonomic modulation, greater variability was observed in prehypertensive patients compared to normotensive individuals (9.4 [4.9-12.7] vs. 18.3 [14.8-26.7] mmHg2; p < 0.01) and higher spectral components of very low (6.9 [2.0-11.1] vs. 13.5 [10.7-22.4] mmHg2, p = 0.01) and low frequencies (1.7 [1.0-3.0] vs. 3.0 [2.0-4.0] mmHg2, p = 0.04) of SBP. Additionally, we observed a lower gain of baroreflex control in prehypertensive patients compared to normotensive patients (12.16 ± 4.18 vs. 18.23 ± 7.11 ms/mmHg, p = 0.03), but similar delay time (-1.55 ± 0.66 vs. -1.58 ± 0.72 s, p = 0.90). Conclusion: Prehypertensive patients with FHSAH have autonomic dysfunction and increased vascular conductance when compared to normotensive patients with the same risk factor.


Resumo Fundamento: Indivíduos com histórico familiar de hipertensão arterial sistêmica (HFHAS) e/ou pré-hipertensão apresentam maior risco de desenvolver essa patologia. Objetivo: Avaliar as funções autonômica e vascular de pré-hipertensos com HFHAS. Métodos: Vinte e cinco voluntários jovens com HFHAS, sendo 14 normotensos e 11 pré-hipertensos foram submetidos à avaliação da função vascular, por meio da condutância vascular do antebraço (CV) durante repouso e hiperemia reativa (Hokanson®), e da modulação autonômica cardíaca e periférica, quantificada, respectivamente, por meio da análise espectral da frequência cardíaca (ECG) e da pressão arterial sistólica (PAS) (FinometerPRO®). A análise da função de transferência foi utilizada para mensurar o ganho e o tempo de resposta do barorreflexo. A significância estatística adotada foi p ≤ 0,05. Resultados: Pré-hipertensos, em relação aos normotensos, tem maior CV tanto em repouso (3,48 ± 1,26 vs. 2,67 ± 0,72 unidades; p = 0,05) quanto no pico hiperemia reativa (25,02 ± 8,18 vs. 18,66 ± 6,07 unidades; p = 0,04). Os índices da modulação autonômica cardíaca foram semelhantes entre os grupos. Entretanto, na modulação autonômica periférica, foi observado, nos pré-hipertensos em relação aos normotensos, maior variabilidade (9,4 [4,9-12,7] vs. 18,3 [14,8-26,7] mmHg2; p < 0,01) e maiores componentes espectrais de muito baixa (6,9 [2,0-11,1] vs. 13,5 [10,7-22,4] mmHg2; p = 0,01) e baixa frequências (1,7 [1,0-3,0] vs. 3,0 [2,0-4,0] mmHg2; p = 0,04) da PAS. Adicionalmente, observamos menor ganho do controle barorreflexo nos pré-hipertensos em relação aos normotensos (12,16 ± 4,18 vs. 18,23 ± 7,11 ms/mmHg; p = 0,03), porém, tempo de retardo semelhante (-1,55 ± 0,66 vs. -1,58 ± 0.72 s; p = 0,90). Conclusão: Pré-hipertensos com HFHAS tem disfunção autonômica e condutância vascular aumentada quando comparados a normotensos com o mesmo fator de risco.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Young Adult , Autonomic Nervous System/physiology , Blood Pressure/physiology , Peripheral Arterial Disease/physiopathology , Prehypertension/physiopathology , Heart Rate/physiology , Hypertension/genetics , Vascular Resistance/physiology , Exercise/physiology , Risk Factors , Hypertension/physiopathology
8.
In. Ramires, José Antonio Franchini; Kalil Filho, Roberto; Santos Filho, Raul Dias dos; Casella Filho, Antonio. Dislipidemias e prevenção da Aterosclerose / Dyslipidemias and prevention of Atherosclerosis. Rio de janeiro, Atheneu, 2018. p.69-75.
Monography in Portuguese | LILACS | ID: biblio-880894
9.
Arch. endocrinol. metab. (Online) ; 61(4): 326-331, July-Aug. 2017. tab
Article in English | LILACS | ID: biblio-887570

ABSTRACT

ABSTRACT Objective Obesity can cause systemic arterial hypertension (SAH) and type 2 diabetes mellitus (DM2) factor that is also influenced by genetic variability. The present study aims to investigate the association between gene polymorphisms related with obesity on the prevalence of SAH and DM2 in the preoperative period and 1 year after Roux-en-Y gastric bypass surgery. Subjects and methods In total, 351 obese women in a Brazilian cohort completed the study. The clinical diagnosis of SAH and DM2 was monitored from medical records. Twelve gene polymorphisms (rs26802; rs572169; rs7799039; rs1137101; rs3813929; rs659366; rs660339; rs1800849; rs7498665; rs35874116; rs9701796; and rs9939609) were determined using real-time polymerase chain reaction and TaqMan assay. Results In the preoperative period, prevalence of SAH and DM2 was 57% and 22%, respectively. One year postoperatively, 86.8% subjects had remission of DM2 and 99.5% had control of SAH. Subjects with T allele from the serotonin receptor gene (5-HT2C, rs3813929) had five times greater chance of DM2, and the CC genotype from uncoupling protein 3 gene (UCP3, rs1800849) had three times greater chance in the preoperative period. Conclusion These findings indicate that polymorphisms rs3813929 and rs1800849 from 5-HT2C and UCP3 genes were related to DM2 prevalence among the Brazilian obese women candidates for bariatric surgery.


Subject(s)
Humans , Female , Adult , Middle Aged , Young Adult , Polymorphism, Genetic , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/epidemiology , Hypertension/genetics , Hypertension/epidemiology , Obesity/genetics , Postoperative Period , Gastric Bypass , Prevalence , Prospective Studies , Preoperative Period , Uncoupling Protein 3/genetics , Obesity/surgery , Obesity/complications
10.
Braz. j. med. biol. res ; 50(12): e6211, 2017. tab, graf
Article in English | LILACS | ID: biblio-888961

ABSTRACT

Recent evidence suggests that cell-derived circulating miRNAs may serve as biomarkers of cardiovascular diseases. However, a few studies have investigated the potential of circulating miRNAs as biomarkers for left ventricular hypertrophy (LVH). In this study, we aimed to characterize the miRNA profiles that could distinguish hypertensive patients with LHV, hypertensive patients without LVH and control subjects, and identify potential miRNAs as biomarkers of LVH. LVH was defined by left ventricular mass indexed to body surface area >125 g/m2 in men and >110 g/m2 in women and patients were classified as hypertensive when presenting a systolic blood pressure of 140 mmHg or more, or a diastolic blood pressure of 90 mmHg or more. We employed miRNA PCR array to screen serum miRNAs profiles of patients with LVH, essential hypertension and healthy subjects. We identified 75 differentially expressed miRNAs, including 49 upregulated miRNAs and 26 downregulated miRNAs between LVH and control patients. We chose 2 miRNAs with significant differences for further testing in 59 patients. RT-PCR analysis of serum samples confirmed that miR-7-5p and miR-26b-5p were upregulated in the serum of LVH hypertensive patients compared with healthy subjects. Our findings suggest that these miRNAs may play a role in the pathogenesis of hypertensive LVH and may represent novel biomarkers for this disease.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Hypertension/blood , Hypertrophy, Left Ventricular/blood , MicroRNAs/blood , Analysis of Variance , Biomarkers/blood , Case-Control Studies , Down-Regulation , Gene Expression Profiling/methods , Hypertension/genetics , Hypertrophy, Left Ventricular/genetics , Predictive Value of Tests , Real-Time Polymerase Chain Reaction , Reference Standards , Reference Values , Risk Factors , Up-Regulation
11.
Medicentro (Villa Clara) ; 20(4): 248-258, oct.-dic. 2016.
Article in Spanish | LILACS | ID: lil-797512

ABSTRACT

La hipertensión arterial es una enfermedad común, que constituye un factor de riesgo de enfermedad cardiovascular, y causa alrededor de 13,5 millones de muertes anuales en el mundo. Más de 65 millones de personas en los Estados Unidos, y un billón en el mundo padecen de hipertensión arterial; en Cuba, en el momento actual, el 33,8 % de los mayores de 18 años presentan esta condición. Varios estudios realizados han demostrado que los niveles individuales de presión sanguínea dependen de la predisposición genética y de factores ambientales. Su componente hereditario ha sido documentado en estudios de familiares, de gemelos, poblacionales, de adopción y, además, se ha descrito una lista de genes candidatos de predisposición. Mediante el desarrollo del proyecto Genoma Humano y con la disponibilidad del mapeo genético, se han identificado cientos de miles de marcadores polimórficos, lo que ha permitido mapear alrededor de 400 marcadores genéticos relacionados con esta enfermedad; por ello, resulta de gran importancia conocer sobre los mecanismos relacionados con las causas de su aparición, incluidas las genéticas y moleculares, para poder trabajar en su prevención y en el mejoramiento de las conductas terapéuticas.


Arterial hypertension is a common disease that constitutes a risk factor of cardiovascular disease and causes about 13.5 million deaths around the world every year. More than 65 million people in the United States and a billion in the world suffer from arterial hypertension; nowadays, in Cuba there are 33.8 % of people older than 18 years with this condition. Some previous studies have demonstrated that individual levels of blood pressure depend on genetic predisposition and environmental factors. Its hereditary component has been documented in family, twin and adoption studies, as well as, a list of predisposing candidate genes has been also described. Hundreds of thousands of polymorphic markers have been identified through the development of the Human Genome Project and the availability of genetic mapping, which has allowed mapping around 400 genetic markers related to this disease; that's why, knowledge about the mechanisms related to the emerging causes of this disease, including molecular and genetic bases, is of great importance in order to work in favor of its prevention and the improvement in therapeutic behaviors.


Subject(s)
Hypertension/genetics
12.
Säo Paulo med. j ; 134(3): 205-210, tab
Article in English | LILACS | ID: lil-785810

ABSTRACT

CONTEXT AND OBJECTIVE: Dimethylarginine dimethylaminohydrolase enzymes (DDAH), which are encoded by the genes DDAH1 and DDAH2, play a fundamental role in maintaining endothelial function. We conducted a case-control study on a Chinese population that included three ethnic groups (Han, Kazakh and Uygur), to systemically investigate associations between variations in the genes DDAH1 and DDAH2 and hypertension. DESIGN AND SETTING: Experimental study at the Department of Internal Medicine and Genetic Diagnosis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. METHODS: This case-control study included 1,224 patients with hypertension and 967 healthy unrelated individuals as controls. DDAH1 -396 4N (GCGT) del>ins, rs3087894, rs805304 and rs9267551 were genotyped using the TaqMan 5' nuclease assay. RESULTS: The G/C genotype of rs3087894 in DDAH1 was a risk factor for hypertension in the Kazakh group in the co-dominant model (G/C versus G/G) (OR 1.39; 95% CI: 1.02-1.88; P < 0.05), with the same result in the dominant model (G/C + C/C versus G/G) (OR 1.38; 95% CI: 1.03-1.84; P < 0.05). In contrast, the C/C genotype of rs3087894 seemed to be a protective factor against hypertension in the Uygur group in the recessive model (C/C versus G/G + G/C) (OR 0.62; 95% CI: 0.39- 0.97; P < 0.05). Similar findings for rs3087894 were also observed after adjusting the variable for the age covariate. CONCLUSION: Our results indicated that the C-allele of rs3087894 in DDAH1 was a risk factor for hypertension in the Kazakh group but a protective factor in the Uygur group.


RESUMO CONTEXTO E OBJETIVO: Enzimas dimetilarginina dimetilaminohidrolase (DDAH), codificadas por genes DDAH1 e DDAH2, desempenham papel fundamental na manutenção da função endotelial. Realizamos estudo tipo caso-controle na população chinesa, com três grupos étnicos (han, kazakh e uygur) para investigar sistematicamente a associação entre a variação de genes DDAH1 e DDAH2 e a hipertensão. DESENHO E LOCAL: Estudo tipo caso-controle no Departamento de Medicina Interna e Diagnóstico Genético, Hospital de Tongji, Tongji Medical College, Universidade de Ciência e Tecnologia de Huazhong. MÉTODOS: Este estudo incluiu 1.224 pacientes com hipertensão e 967 indivíduos saudáveis, sem parentesco, como controles. DDAH1 -396 4 N (GCGT) del > ins, rs3087894, rs805304 and rs9267551 foram genotipados usando o ensaio nuclease TaqMan 5'. RESULTADOS: O genótipo G/C de rs3087894 no DDAH1 foi um fator de risco para a hipertensão arterial no grupo kazakh em modelo codominante (G/C versus G/G; OR 1,39; IC 95%: 1,02-1,88; P < 0,05), com o mesmo resultado no modelo dominante (G/C + C/C versus G/G; OR 1,38; IC 95%: 1,03-1,84; P < 0,05). Em contraste, o genótipo C/C de rs3087894 parecia ser um fator de proteção para a hipertensão no grupo uygur no modelo recessivo (C/C versus G/G + G/C; OR 0,62; IC 95%: 0,39-0,97; P < 0,05). Achado semelhante para rs3087894 também foi observado depois de se ajustar a variante à covariante idade. CONCLUSÃO: Os nossos resultados indicaram que o C-alelo de rs3087894 no DDAH1 foi fator de risco para a hipertensão no grupo de kazakh, mas fator de proteção no grupo de uygur.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Genetic Variation , Asian Continental Ancestry Group/genetics , Amidohydrolases/genetics , Hypertension/genetics , Base Sequence , Ethnic Groups/genetics , Case-Control Studies , China/ethnology , Risk Factors , Genotype , Hypertension/epidemiology
13.
Article in English | LILACS | ID: lil-785236

ABSTRACT

ABSTRACT Objective Metabolic syndrome (MetS) is associated with hypertension, obesity and dyslipidemia. Thus, genetic variants related with these conditions may modulate its development. We evaluated the effect of polymorphisms in the renin-angiotensin system (RAS) on metabolic syndrome risk in a cohort of Chilean subjects. Subjects and methods A total of 152 subjects, 83 with MetS (51.2 ± 9.6 years) and 69 without MetS (49.5 ± 9.3 years) of both genders were included, according to the ATP III update criteria. The rs4340 Insertion/Deletion (I/D), rs699 (T>C) and rs5186 (A>C) of the ACE, AGT and AGTR1 genes, respectively, were genotyped. Results After adjusting for age and gender, we observed the DD genotype of rs4340 associated with MetS (p = 0.02). Specifically, the DD genotype was associated with MetS risk in women (OR = 4.62, 95%CI, 1.41 – 15.04; p < 0.01). In males, the AA genotype for rs5186 variant was associated with an increased risk for developing MetS when compared with women carrying the same genotype (OR = 3.2; 95%CI, 1.03 – 9.89; p = 0.04). In subjects without MetS, DD genotype was associated with increased waist circumference (p = 0.023) while subjects with MetS carrying the rs5186 TT genotype showed higher levels of HDL-cholesterol (p = 0.031). Conclusion The present study contributes data highlighting the role for RAS polymorphisms in predisposing to metabolic syndrome in Chilean subjects.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Polymorphism, Genetic , Renin-Angiotensin System/genetics , Metabolic Syndrome/genetics , Hypertension/genetics , Chile , Sex Factors , Angiotensinogen/genetics , Cross-Sectional Studies , Cohort Studies , Age Factors , Gene Deletion , Peptidyl-Dipeptidase A/genetics , Genetic Predisposition to Disease , Receptor, Angiotensin, Type 1/genetics , Genotype
14.
Arq. bras. cardiol ; 106(5): 411-418, May 2016. tab
Article in English | LILACS | ID: lil-784175

ABSTRACT

Abstract Background: Arterial hypertension is a major public health problem and has increased considerably in young individuals in past years. Thus, identifying factors associated with this condition is important to guide intervention strategies in this population. Objective: To determine high blood pressure prevalence and its associated factors in adolescents. Methods: A random sample of 1,242 students enrolled in public schools of the city of Curitiba (PR) was selected. Self-administered questionnaires provided family history of hypertension, daily energy expenditure, smoking habit, daily fat intake, and socioeconomic status. Waist circumference was measured following standardized procedures, and blood pressure was measured with appropriate cuffs in 2 consecutive days to confirm high blood pressure. Relative frequency and confidence interval (95%CI) indicated high blood pressure prevalence. Bivariate and multivariate analyses assessed the association of risk factors with high blood pressure. Results: The high blood pressure prevalence was 18.2% (95%CI 15.2-21.6). Individuals whose both parents had hypertension [odds ratio (OR), 2.22; 95%CI 1.28-3.85] and those with high waist circumference (OR, 2.1; 95%CI 1.34-3.28) had higher chances to develop high blood pressure. Conclusion: Positive family history of hypertension and high waist circumference were associated with high blood pressure in adolescents. These factors are important to guide future interventions in this population.


Resumo Fundamento: A hipertensão arterial é um grave problema de saúde pública e, nos últimos anos, tem aumentado consideravelmente em jovens. A identificação de fatores associados com essa condição é importante para guiar estratégias de intervenção nessa população. Objetivo: Determinar a prevalência e os fatores associados com a pressão arterial alterada em adolescentes. Métodos: Foi selecionada amostra probabilística de 1.242 adolescentes da rede pública de ensino de Curitiba (PR). Por meio de questionários, foram obtidos o histórico familiar de hipertensão, o gasto energético diário, informações sobre tabagismo, o consumo diário de gorduras e a classificação econômica. A circunferência da cintura foi medida por procedimentos padronizados. A pressão arterial foi aferida com manguitos adequados em 2 dias consecutivos para a confirmação da pressão arterial alterada. Frequências relativas e intervalos de confiança (IC95%) indicaram a prevalência de pressão arterial alterada. Regressões logística bivariadas e multivariadas testaram a associação dos fatores de risco com a pressão arterial alterada. Resultados: A prevalência de pressão arterial alterada foi de 18,2% (IC95% 15,2-21,6). Mais chances de pressão arterial alterada foram encontradas nos indivíduos que possuíam ambos os pais com hipertensão arterial [odds ratio (OR), 2,22; IC95% 1,28-3,85] e naqueles com a circunferência da cintura aumentada (OR, 2,1; IC95% 1,34-3,28). Conclusão: O histórico familiar positivo de hipertensão arterial e a circunferência da cintura aumentada estiveram associados a pressão arterial alterada em adolescentes. Esses fatores são importantes para guiar intervenções futuras nessa população.


Subject(s)
Humans , Male , Female , Adolescent , Blood Pressure/physiology , Hypertension/epidemiology , Brazil/epidemiology , Sex Factors , Epidemiologic Methods , Sex Distribution , Hypertension/genetics
15.
Rev. chil. endocrinol. diabetes ; 9(1): 19-26, ene. 2016. tab, ilus
Article in Spanish | LILACS | ID: biblio-831339

ABSTRACT

Background: Treatment of dendritic cells (DC) with aldosterone induces the secretion of IL-6 and TGF-beta. The polarization of naïve T cells to helper 17 T lymphocytes with DCs pre-incubated with aldosterone, has been described in vivo, generating an IL-17 hyper-secreting phenotype, a cytokine associated with cardiac and renal fibrosis. There are mineralocorticoid receptors (MR) in immune cells and their activation may determine the inflammatory (M1) or adaptive (M2) macrophage phenotype. Aldosterone levels could regulate immunogenic gene expression in these cells, modulating the liberation of specific cytokines. Aim: To assess in humans the association of aldosterone levels and IL-17 with inflammatory markers in peripheral blood mononuclear cells (PBMC). Material and Methods: In blood samples of 176 participants aged 18 to 67 years (61 percent women) with a body mass index of 27.1 +/- 4.8 kg/m2, aldosterone, plasma renin activity (ARP), cortisol, C reactive protein, andIL-17 were measured. mRNA was isolated from PBMCs to measure the expression of MR RAC-1, HO-1, TLR-4, CD-14, NGAL and IL-17 by real time polymerase chain reaction. Results: Aldosterone correlated positively with ARP and the expression of CD-14 in PBMCs. Plasma levels of IL-17 were positively associated with the expression of MR, Rac1a and NGAL. Conclusions: Aldosterone and IL-17 levels were associated with inflammatory activation markers in PBMC, which could activate MRand promote a subclinical inflammatory status inducing hypertension.


Subject(s)
Humans , Male , Adolescent , Adult , Female , Young Adult , Middle Aged , Aldosterone/genetics , Hypertension/genetics , Hypertension/blood , /genetics , Aldosterone/blood , Biomarkers , Gene Amplification , /blood , Real-Time Polymerase Chain Reaction , Receptors, Mineralocorticoid
16.
Rev. Assoc. Med. Bras. (1992) ; 61(3): 234-239, May-Jun/2015. tab
Article in English | LILACS | ID: lil-753176

ABSTRACT

Summary Objectives: to analyze factors that might indicate familial predisposition for ovarian cancer in patients diagnosed with this disease. Methods: in a prospective single center cohort study at the Institute of Cancer of the State of São Paulo (ICESP), 51 women diagnosed with ovarian cancer were included. Familial predisposition for ovarian cancer was defined as having a higher than 10% chance of having a BRCA1/2 mutation according to the Manchester scoring system, a validated method to assess the likelihood of mutation detection. Each patient was interviewed with a standardized questionnaire on established risk factors for ovarian cancer and other factors that might influence the risk to develop ovarian cancer. Logistic regression analyses were performed to estimate the impact of the evaluated factors on the likelihood of mutation detection, by calculating odds ratios and 95% confidence intervals. Results: seventeen out of 51 patients had a family history of breast and/or ovarian cancer, four patients had a history of breast or endometrial cancer, 11 were diagnosed before the age of 50, and 12 presented a risk of familial predisposition to ovarian cancer higher than 10%. Patients with comorbidities, such as hypertension, diabetes, hormonal disorders, dyslipidemia and psychiatric conditions, presented a lower chance of having a familial predisposition for ovarian cancer (OR: 0.22; 95% CI: 0.06-0.88; p=0.03). Conclusion: in this study, having comorbidities was associated with a lower risk of having a familial predisposition for ovarian cancer. Other factors associated with the risk of ovarian cancer did not have an impact on this predisposition. .


Resumo Objetivos: analisar fatores que possam indicar uma predisposição familiar ao câncer de ovário em pacientes com este diagnóstico. Métodos: em estudo de coorte prospectiva realizado no Instituto do Câncer do Estado de São Paulo (ICESP), foram incluídas 51 mulheres diagnosticadas com câncer de ovário entre janeiro de 2009 e dezembro de 2011. Predisposição familiar para câncer de ovário foi definida como um risco maior de 10% de apresentar uma mutação em BRCA1/2, de acordo com o sistema de pontes de Manchester, um método validado para avaliar a probabilidade de detecção de mutação nesses genes. Cada paciente foi entrevistada com um questionário padronizado, abordando fatores de risco para câncer de ovário e outros fatores que pudessem influenciar o risco de desenvolver a doença. O impacto dos fatores avaliados na probabilidade de detecção da mutação foi avaliado com regressões logísticas. Resultados: dezessete das 51 pacientes referiram história familiar de câncer de mama e/ou ovário, quatro pacientes apresentavam antecedente pessoal de câncer de mama ou endométrio, 11 haviam sido diagnosticadas antes dos 50 anos e 12 apresentaram um risco maior que 10% de predisposição familiar a câncer de ovário. Pacientes com comorbidades como hipertensão, diabetes, disfunções hormonais, dislipidemia e distúrbios psiquiátricos apresentaram menor risco de predisposição familiar ao câncer de ovário (OR: 0.22; IC 95%: 0.06-0.88; p=0.03). Conclusão: neste estudo, apresentar alguma comorbidade foi associado a um menor risco de ter uma predisposição familiar ao câncer de ovário. Outros fatores associados ao risco de câncer de ovário não tiveram nenhum impacto sobre esta predisposição. .


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Cystadenocarcinoma, Serous/genetics , Genetic Predisposition to Disease , Hereditary Breast and Ovarian Cancer Syndrome/genetics , Hypertension/genetics , Ovarian Neoplasms/genetics , Age Factors , Body Mass Index , Cohort Studies , Comorbidity , Genes, BRCA1 , Life Style , Prospective Studies , Risk Factors , Surveys and Questionnaires
17.
Yonsei Medical Journal ; : 227-234, 2015.
Article in English | WPRIM | ID: wpr-174629

ABSTRACT

PURPOSE: The aim of the present study was to investigate associations between the renin gene (REN) and the risk of essential hypertension and blood pressure (BP) levels in Koreans. MATERIALS AND METHODS: To outline the functional role of a single nucleotide polymorphism in the transcription of the REN gene, we conducted a case-control study of 1975 individuals: 646 hypertension (HT) patients and 1329 ethnically and age-matched normotensive subjects. RESULTS: Logistic regression analysis indicated that the genotypes AA/AG were strongly associated with risk of HT (odds ratio, 1.493; 95% confidence interval, 1.069-2.086, p=0.018) in female subjects. The genotypes AA/AG also showed significant association with higher blood pressure levels, both systolic and diastolic, in postmenopausal HT women (p=0.003 and p=0.017, respectively). Analysis of the promoter containing rs6682082 revealed a 2.4+/-0.01-fold higher activity in the A variant promoter than the G variant promoter, suggesting that rs6682082 is itself a functional variant. CONCLUSION: We suggest that the A allele of rs6682082 is a positive genetic marker for predisposition to essential hypertension and high BP in Korean women and may be mediated through the transcriptional activation of REN.


Subject(s)
Alleles , Asian Continental Ancestry Group/genetics , Blood Pressure/genetics , Case-Control Studies , Diastole/genetics , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Hypertension/genetics , Luciferases/metabolism , Middle Aged , Polymorphism, Single Nucleotide/genetics , Promoter Regions, Genetic/genetics , Renin/genetics , Republic of Korea , Risk Factors , Systole/genetics , Transfection
18.
Clinics ; 69(3): 179-184, 3/2014. tab
Article in English | LILACS | ID: lil-703600

ABSTRACT

OBJECTIVES: We aimed to investigate whether glucocorticoid receptor gene polymorphisms are associated with clinical and metabolic profiles in patients with polycystic ovary syndrome. Polycystic ovary syndrome is a complex endocrine disease that affects 5-8% of women and may be associated with metabolic syndrome, which is a risk factor for cardiovascular disease. Cortisol action and dysregulation account for metabolic syndrome development in the general population. As glucocorticoid receptor gene (NR3C1) polymorphisms regulate cortisol sensitivity, we hypothesized that variants of this gene may be involved in the adverse metabolic profiles of patients with polycystic ovary syndrome. METHOD: Clinical, metabolic and hormonal profiles were evaluated in 97 patients with polycystic ovary syndrome who were diagnosed according to the Rotterdam criteria. The alleles of the glucocorticoid gene were genotyped. Association analyses were performed using the appropriate statistical tests. RESULTS: Obesity and metabolic syndrome were observed in 42.3% and 26.8% of patients, respectively. Body mass index was positively correlated with blood pressure, triglyceride, LDL-c, total cholesterol, glucose and insulin levels as well as HOMA-IR values and inversely correlated with HDL-c and SHBG levels. The BclI and A3669G variants were found in 24.7% and 13.4% of alleles, respectively. BclI carriers presented a lower frequency of insulin resistance compared with wild-type subjects. CONCLUSION: The BclI variant is associated with a lower frequency of insulin resistance in women with polycystic ovary syndrome. Glucocorticoid gene polymorphism screening during treatment of the syndrome may be useful for identifying subgroups of at-risk patients who would benefit the most from personalized treatment. .


Subject(s)
Adult , Female , Humans , Young Adult , Polycystic Ovary Syndrome/genetics , Polycystic Ovary Syndrome/metabolism , Polymorphism, Genetic/genetics , Receptors, Glucocorticoid/genetics , Alleles , Body Mass Index , Cholesterol , Fluoroimmunoassay , Gene Frequency , Genes, bcl-1/genetics , Hypertension/genetics , Hypertension/metabolism , Insulin Resistance/genetics , Metabolic Syndrome/genetics , Metabolic Syndrome/metabolism , Obesity/genetics , Obesity/metabolism , Polymerase Chain Reaction , Risk Factors , Statistics, Nonparametric , Time Factors
19.
Biomédica (Bogotá) ; 33(4): 598-614, Dec. 2013. ilus, tab
Article in Spanish | LILACS | ID: lil-700478

ABSTRACT

Introducción. La hipertensión arterial es una enfermedad multifactorial influenciada por componentes genéticos y ambientales, cuya prevalencia varía entre grupos étnicos. Se han llevado a cabo numerosos estudios en genes de sistemas reguladores de la presión arterial, como el sistema renina-angiotensinaaldosterona, el sistema nervioso simpático, los factores endoteliales, y el balance de sodio, mostrando resultados incongruentes entre poblaciones. Objetivos. Evaluar el efecto de variantes en los genes AGT , AGTR1 , ACE , ADRB2 , DRD1 , ADD1 , ADD2 , ATP2B1 , TBXA2R y PTGS2 y del componente ancestral individual, sobre la hipertensión arterial y las cifras de presión arterial en una muestra de población antioqueña. Materiales y métodos. Se genotipificaron 107 casos y 253 controles para 12 variantes en los genes AGT , AGTR1 , ACE , ADRB2 , DRD1 , ADD1 , ADD2 , ATP2B1 , TBXA2R y PTGS2 , y para 20 marcadores informativos de ascendencia. Se evaluó la asociación de los polimorfismos y sus interacciones, y de la composición genética ancestral con hipertensión y cifras de presión arterial. Resultados. Los genes ADD2 , rs4852706 (OR=3,0; p=0,023); DRD1 , rs686 (OR=0,38; p=0,012) y ADRB2 , rs1042718 (OR=10,0; p=0,008); y combinaciones genotípicas de DRD1 con AGTR1 ; de AGT con ADD1 ; y de ADD1 con ATP2B1 y PTGS2 , se asociaron con hipertensión arterial. El componente ancestral amerindio se asoció con disminución en la presión arterial diastólica. Conclusiones. Variantes en los genes ADD2 , DRD1 , ADRB2 , AGTR1 , AGT , ADD1 , ATP2B1 y PTGS2 , individualmente o en su interacción, se encuentran asociadas con hipertensión. El componente ancestral amerindio tiene un efecto sobre las cifras de presión arterial.


Introduction: Hypertension is a multifactorial disease influenced by genetic and environmental components, with its prevalence varying across ethnic groups. Manifold studies on blood pressure regulatory system genes have been carried out -such as the renin-angiotensin-aldosterone system, the sympathetic nervous system, endothelial factor, and sodium balance-, but the results yielded were inconsistent among populations. Objectives: To evaluate the effect of both variants in genes AGT, AGTR1, ACE, ADRB2, DRD1, ADD1, ADD2, ATP2B1, TBXA2R PTGS2, and the result of the individual ancestry component on hypertension and blood pressure levels among population in Antioquia. Methods and materials: 107 cases and 253 controls were genotyped for 12 variants on genes AGT, AGTR1, ACE, ADRB2, DRD1, ADD1, ADD2, ATP2B1, TBXA2R y PTGS2, and for 20 ancestry informative markers. The association of polymorphisms and their interactions, and the association of ancestral genetic composition with hypertension and blood pressure levels were examined. Results: Genes ADD2, rs4852706 (OR=3.0; p=0.023); DRD1, rs686 (OR=0.38; p=0.012) and ADRB2, rs1042718 (OR=10.0; p=0.008); as well as genotypic combinations of DRD1 and AGTR1; AGT and ADD1; and ADD1 to ATP2B1 and PTGS2 were associated to hypertension. The Amerindian ancestry component was associated to some decrease in diastolic blood pressure. Conclusion: Variants on genes ADD2, DRD1, ADRB2, AGTR1, AGT, ADD1, ATP2B1 and PTGS2 individually or interacting, are associated to hypertension. The Amerindian ancestry component has an effect on blood pressure.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Hypertension/genetics , Angiotensinogen/genetics , Blood Pressure/genetics , Colombia , Calmodulin-Binding Proteins/genetics , /genetics , Peptidyl-Dipeptidase A/genetics , Plasma Membrane Calcium-Transporting ATPases/genetics , Risk Factors , Receptor, Angiotensin, Type 1/genetics , /genetics , Receptors, Dopamine D1/genetics , /genetics
20.
Clinics ; 68(11): 1428-1432, 1jan. 2013. tab
Article in English | LILACS | ID: lil-690627

ABSTRACT

OBJECTIVE: The angiotensin-converting enzyme gene is one of the most studied candidate genes related to atrial fibrillation. Among the polymorphisms of the angiotensin-converting enzyme gene, the 2350 G/A polymorphism (rs4343) is known to have the most significant effects on the plasma angiotensin-converting enzyme concentration. The aim of the present study was to investigate the association of the angiotensin-converting enzyme 2350 G/A polymorphism with atrial fibrillation in Han Chinese patients with essential hypertension. METHODS: A total of 169 hypertensive patients were eligible for this study. Patients with atrial fibrillation (n = 75) were allocated to the atrial fibrillation group, and 94 subjects without atrial fibrillation were allocated to the control group. The PCR-based restriction fragment length polymorphism technique was used to assess the genotype frequencies. RESULTS: The distributions of the angiotensin-converting enzyme 2350 G/A genotypes (GG, GA, and AA, respectively) were 40.43%, 41.49%, and 18.08% in the controls and 18.67%, 46.67%, and 34.66% in the atrial fibrillation subjects (p = 0.037). The frequency of the A allele in the atrial fibrillation group was significantly greater than in the control group (58.00% vs. 38.83%, p = 0.0007). Compared with the wild-type GG genotype, the GA and AA genotypes had an increased risk for atrial fibrillation. Additionally, atrial fibrillation patients with the AA genotype had greater left atrial dimensions than the patients with the GG or GA genotypes (p<0.01 and p<0.05, respectively). CONCLUSIONS: The results obtained in this study indicate that the angiotensin-converting enzyme 2350 G/A polymorphism is associated with atrial fibrillation and that the A allele shows an increased risk for atrial fibrillation in Han Chinese patients with essential hypertension. .


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Atrial Fibrillation/genetics , Hypertension/genetics , Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic/genetics , Age Factors , Asian Continental Ancestry Group/genetics , Body Mass Index , Blood Pressure/genetics , China , Gene Frequency , Genetic Predisposition to Disease , Polymerase Chain Reaction , Risk Factors , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL